Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
URUSA in Functional Dyspepsia Patients with Small Intestinal Bacterial Overgrowth
KCT0004910Phase 4Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ursodeoxycholic acid in functional dyspepsia (FD), blind loop syndrome (BLS), sponsored by Daewoong Pharmaceutical. Started Jul 2019; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
functional dyspepsia (FD)blind loop syndrome (BLS)
Beyond the preview
Go deeper on KCT0004910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004910.